Alerts will be sent to your verified email
Verify Email
LINKPH
|
Link Pharma Chem
|
Ortin Global
|
Beryl Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.59 % | -64.74 % | 3.64 % |
|
5yr average Equity Multiplier
|
1.99 | 2.06 | 2.12 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 0.28 | 1.19 |
|
5yr Avg Net Profit Margin
|
-0.06 % | -124.59 % | 1.13 % |
|
Price to Book
|
0.99 | 10.01 | 1.27 |
|
P/E
|
0.0 | 0.0 | 49.39 |
|
5yr Avg Cash Conversion Cycle
|
82.44 Days | 1016.26 Days | -589.78 Days |
|
Inventory Days
|
64.96 Days | 326.59 Days | 36.09 Days |
|
Days Receivable
|
72.97 Days | 1081.4 Days | 112.55 Days |
|
Days Payable
|
84.21 Days | 645.07 Days | 964.25 Days |
|
5yr Average Interest Coverage Ratio
|
2.35 | -64.13 | 1.91 |
|
5yr Avg ROCE
|
5.35 % | -34.49 % | 7.2 % |
|
5yr Avg Operating Profit Margin
|
3.76 % | -107.87 % | 6.72 % |
|
5 yr average Debt to Equity
|
0.49 | 0.51 | 0.59 |
|
5yr CAGR Net Profit
|
n/a | n/a | 19.3 % |
|
5yr Average Return on Assets
|
0.6 % | -25.0 % | 1.98 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.49 % | 1.23 % | 26.38 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -14.45 % | 1.46 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Link Pharma Chem
|
Ortin Global
|
Beryl Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|